These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31147526)

  • 21. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K/AKT/FOXO3a axis and TNF signaling pathway.
    Dinghuan W; Yi K; Jianzhi T; Wenfei W; Chunlin W; Anling H; Zhixu H; Ben-David Y; Sheng L; Xiaoyan Y; Xiao X
    Biomed Pharmacother; 2024 Aug; 177():117071. PubMed ID: 38981243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
    Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
    J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
    Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W
    J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-7 inhibits cell proliferation of chronic myeloid leukemia and sensitizes it to imatinib in vitro.
    Jiang MJ; Dai JJ; Gu DN; Huang Q; Tian L
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):372-378. PubMed ID: 28986256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.
    Zhang X; Zeng J; Zhou M; Li B; Zhang Y; Huang T; Wang L; Jia J; Chen C
    Mol Cancer; 2012 Aug; 11():56. PubMed ID: 22900969
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Zhang TJ; Zhou JD; Zhang W; Lin J; Ma JC; Wen XM; Yuan Q; Li XX; Xu ZJ; Qian J
    Clin Epigenetics; 2018; 10():47. PubMed ID: 29643943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.
    Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA; Cocco L
    Curr Med Chem; 2007; 14(19):2009-23. PubMed ID: 17691943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid precursor protein cooperates with c-KIT mutation/overexpression to regulate cell apoptosis in AML1-ETO-positive leukemia via the PI3K/AKT signaling pathway.
    Yu G; Yin C; Jiang L; Zheng Z; Wang Z; Wang C; Zhou H; Jiang X; Liu Q; Meng F
    Oncol Rep; 2016 Sep; 36(3):1626-32. PubMed ID: 27460334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia.
    Gong JN; Yu J; Lin HS; Zhang XH; Yin XL; Xiao Z; Wang F; Wang XS; Su R; Shen C; Zhao HL; Ma YN; Zhang JW
    Cell Death Differ; 2014 Jan; 21(1):100-12. PubMed ID: 24076586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CircDDX42 Accelerates the Development of Pancreatic Cancer via miR-613/ID4/PI3K/AKT Axis.
    Yan Z; Yin H; Lin G
    Onco Targets Ther; 2020; 13():10945-10957. PubMed ID: 33149610
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Zhao J; Liu J; Liu S; Tian S; Yuan H; Li S
    Epigenomics; 2023 Mar; 15(6):369-383. PubMed ID: 37212125
    [No Abstract]   [Full Text] [Related]  

  • 38. MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients' prognosis.
    Xu Y; Li K; Wang SB; Yang SG
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1610-1619. PubMed ID: 30840284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia.
    Prijić S; Ugrina I; Labar B; Nemet D; Batinić J; Zadro R; Ries S; Gjadrov-Kuvedžić K; Davidović S; Batinić D
    Leuk Lymphoma; 2015; 56(8):2281-8. PubMed ID: 25426669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.